Biodexa Pharmaceuticals (BDRX) Other Non-Current Liabilities (2018 - 2026)
Biodexa Pharmaceuticals (BDRX) recorded Other Non-Current Liabilities of $444,096 in the quarter ended Jun 30, 2026, down 63.4% from $1.21 million a year earlier.
Powered by 
Analysis
Biodexa Pharmaceuticals (BDRX) Other Non-Current Liabilities (2018 - 2026) Analysis & Trends
As of Dec 31, 2025, Biodexa Pharmaceuticals reported Other Non-Current Liabilities of $850,439, down 49.1% from the prior year.
- Annual Other Non-Current Liabilities has a five-year compound annual growth rate of -15.7% (years ended Dec 2020 to Dec 2025).
- Across earlier years, Other Non-Current Liabilities came in at $1.67 million in the year ended Dec 31, 2024 (-67.7%), $5.17 million in the year ended Dec 31, 2023, $105,197 in the year ended Dec 31, 2022 (-86.2%) and $760,861 in the year ended Dec 31, 2021 (-62.0%).
- The figure for the quarter ended Jun 30, 2026 is the lowest quarterly Other Non-Current Liabilities since the quarter ended Dec 31, 2022.
- Peak year-over-year performance for Other Non-Current Liabilities in the last five years was growth of 330.1% in the quarter ended Jun 30, 2024, against a decline of 91.4% in the quarter ended Jun 30, 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Biodexa Pharmaceuticals | 41.69 Mn | 18.48 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 444,095.58 |
| Dec 31, 2025 | 857,957.20 |
| Jun 30, 2025 | 1.21 Mn |
| Dec 31, 2024 | 1.68 Mn |
| Jun 30, 2024 | 1.96 Mn |
| Dec 31, 2023 | 5.16 Mn |
| Jun 30, 2023 | 455,496.19 |
| Dec 31, 2022 | 99,698.91 |
| Jun 30, 2022 | 195,193.70 |
| Dec 31, 2021 | 745,449.87 |
| Jun 30, 2021 | 2.27 Mn |
| Dec 31, 2020 | 2.06 Mn |
| Jun 30, 2020 | 1.43 Mn |
| Dec 31, 2019 | 853,721.34 |
| Jun 30, 2019 | -100,332.38 |
| Dec 31, 2018 | -603,493.83 |
API Access
Biodexa Pharmaceuticals Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=BDRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "BDRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=BDRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();